CA
EDIT icon

CoreCap Advisors’s Editas Medicine EDIT Stock Holding History

CoreCap Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-15
Closed -$49 – 3218
2026
Q2 		$49 Hold
15
– – ﹤0.01% 3118
2026
Q1 		$37 Hold
15
– – ﹤0.01% 2891
2025
Q4 		$31 Hold
15
– – ﹤0.01% 2920
2025
Q3 		$52 Sell
15
-100
-87% -$279 ﹤0.01% 2753
2025
Q2 		$253 Hold
115
– – ﹤0.01% 2596
2025
Q1 		$133 Hold
115
– – ﹤0.01% 3036
2024
Q4 		$146 Sell
115
-215
-65% -$548 ﹤0.01% 2750
2024
Q3 		$1.13K Sell
330
-170
-34% -$740 ﹤0.01% 2253
2024
Q2 		$2.33K Buy
+500
New +$2.82K ﹤0.01% 1296
2022
Q4 		$648 Buy
+73
New +$801 ﹤0.01% 2129
2022
Q3 		– Sell
-73
Closed -$1K – 948
2022
Q2 		$1K Buy
+73
New +$978 ﹤0.01% 1974
2022
Q1 		– Sell
-73
Closed -$2K – 957
2021
Q4 		$2K Buy
+73
New +$2.51K ﹤0.01% 1942

Other funds holding EDIT

GAA
Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return
DIM
DLK Investment Management Solana Beach, California $275M AUM 10.69% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

CoreCap Advisors's EDIT Position: Q3 2026 in Review

CoreCap Advisors sold out of Editas Medicine (EDIT) in Q3 2026, closing a stake of 15 shares — an estimated $49 sold.

CoreCap Advisors first reported a position in EDIT in Q4 2021 and held it in 12 quarters. The position peaked at $2.33K in Q2 2024. 7 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.

  • CoreCap Advisors reported no remaining Editas Medicine position as of Q3 2026 after selling out during the quarter.
  • CoreCap Advisors sold 15 Editas Medicine shares in Q3 2026, an estimated $49.
  • CoreCap Advisors first reported a position in Editas Medicine in Q4 2021 and held it in 12 quarters.
  • CoreCap Advisors's Editas Medicine position peaked at $2.33K in Q2 2024.
  • 7 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.